Table 5.
Studies assessing OTC products for combinations of conditions
| Study Details | Product used | Comparator used | Measure(s) used | Effective? | Side effects |
|---|---|---|---|---|---|
|
Etedali et al., 2022 [47] Iran N = 63 Comorbidity-prostate cancer |
Melatonin 3 mg twice a day 4 weeks |
No treatment |
PSQI HAM-A BDI |
Yes (for insomnia, not depression or anxiety) | Excessive daytime sleepiness with melatonin |
|
Yu et al., 2019 [68] China N = 90 Comorbidity- Obstructive sleep apnoea |
1. Rhodiola rosea L. 0.6 g twice a day 2. Rhodiola rosea L. + CPAP machine 3 months |
CPAP machine only |
SDS SAS |
Yes for depression and anxiety when used with CPAP but not alone | Not reported |
BDI Beck Depression Inventory, HAM-A Hamilton Anxiety Rating Scale, PSQI Pittsburgh Sleep Quality Index, SAS Self-rating Anxiety Scale, SDS Self-rating Depression Scale